lenalidomide has been researched along with Tuberculosis, Meningeal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Freedman, VH; Kaplan, G; Mangaliso, B; Muller, G; Stirling, D; Tsenova, L | 1 |
1 other study(ies) available for lenalidomide and Tuberculosis, Meningeal
| Article | Year |
|---|---|
Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.
Topics: Animals; Antitubercular Agents; Brain; Central Nervous System; Female; Immunosuppressive Agents; Lenalidomide; Male; Meninges; Mycobacterium bovis; Rabbits; Thalidomide; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2002 |